REINACH, Switzerland–(BUSINESS WIRE)–Evolva (SIX: EVE), which develops and commercializes next-generation
specialty ingredients for health, wellness and nutrition markets,
details the next phase of its corporate evolution.
Evolva announced in its half year results further details of its future
intended strategic direction to aggressively grow product revenues and
accelerate the path to a cash flow break-even position. In order to
exploit the full potential of its own products in various applications
and geographies, the company will enter commercial collaborations with
market leading companies in addition to selected direct sales. It will
also main…
Read the full article at: http://www.businesswire.com/news/home/20170829006042/en/Evolva-Announces-Major-Restructuring-Phase-Development